NCT01136941 Trial of Zileuton CR in Children and Adults With Sickle Cell Disease Status COMPLETED Phase PHASE1
NCT01123863 The Brigance Assessment Of Individual Neurodevelopment In Young Children With Sickle Cell Disease- 2 Status COMPLETED Phase N/A
NCT01123369 Spectralis HRA+OCT Imaging of the Retina With Autofluorescence in Sickle Cell Disease Status COMPLETED Phase N/A
NCT01119833 Study of GMI-1070 for the Treatment of Sickle Cell Pain Crisis Status COMPLETED Phase PHASE2
NCT01105923 Study of an Intervention to Improve Problem List Accuracy and Use Status UNKNOWN Phase NA
NCT01096121 Angiotensin-converting Enzyme Inhibitors and Early Sickle Cell Renal Disease in Children Status TERMINATED Phase NA
NCT01090323 Evaluation of the Safety, Tolerability, Pharmacokinetics (PK) and Effects on Liver Iron Concentration of ICL670 Relative to Deferoxamine(DFO). Status COMPLETED Phase PHASE2
NCT01089439 Nitric Oxide Therapy for Acute Chest Syndrome in Sickle Cell Disease Children Status COMPLETED Phase PHASE2
NCT01085201 Adenosine 2A Agonist Lexiscan in Children and Adults With Sickle Cell Disease Status COMPLETED Phase PHASE1
NCT01077921 Study of Propranolol as Anti-Adhesive Therapy in Sickle Cell Disease (SCD) Status COMPLETED Phase PHASE2
NCT01058473 Psychometric Evaluation of the IPPAQ in Pediatric Patients With Sickle Cell Disease Hospitalized With Vasoocclusive Pain Status COMPLETED Phase N/A
NCT01049854 CD34+Selection for Partially Matched Family or Matched Unrelated Adult Donor Transplant Status COMPLETED Phase PHASE2
NCT01048905 Glutamine Therapy for Hemolysis-Associated Pulmonary Hypertension Status COMPLETED Phase PHASE2
NCT01033227 Safety and Efficacy of Sodium Nitrite in Sickle Cell Disease Status TERMINATED Phase PHASE1/PHASE2
NCT01000155 Efficacy of Vorinostat to Induce Fetal Hemoglobin in Sickle Cell Disease Status TERMINATED Phase PHASE2
NCT00999245 THE IMPROVE TRIAL: Improving Pain Management and Outcomes With Various Strategies of Patient-Controlled Analgesia (PCA) Status TERMINATED Phase PHASE3
NCT00972231 Iron Overload and Growth Velocity in Thalassemia and Sickle Cell Anemia Status COMPLETED Phase N/A
NCT00968162 Sickle Cell Disease Conditioning for Bone Marrow Transplant Status COMPLETED Phase PHASE1